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1. Introduction 
1.1. Steroid hormones and hormonal contraceptive drugs 
Generally, progestogens, i.e. progesterone in combination with oestradiol esters, are used 
primarily in the treatment of menstrual irregularities to maintain endangered pregnancies. 
Their derivatives are orally active medroxyprogesterone acetate including 
hydroxyprogesterone caproate, chlormadinone acetate, megestrol acetate. Naturally 
occurring glucocorticoids are often used in medicine such as cortisone, hydrocortisone, 
prednisone and prednisolone (Fig. 1). Depot-medroxyprogesterone acetate (Depot-MPA) is 
commercially available and commonly known as a hormonal contraception used by women. 
It is a synthetic steroid hormone, which mimics natural progesterone, but its contraceptive 
activity has been shown to be about 30 times higher. Depot-MPA is widely used by 
intramuscular administration for long-term contraception [1-3].  
Research concerning its pharmacokinetics has been performed in order to improve the 
hormonal activity of the drug formulation [2,4]. This will help to standardize the dosage of 
the drug.  
1.2. Determination of MPA in hormonal contraceptive drugs 
Analysis of MPA in plasma or serum has been performed to study its pharmacokinetics and 
to monitor its residual levels in cancer patients after oral or intramuscular administration 
[4,5]. Numerous recent researches for this analysis have been reported concerning the 
method sensitivity and selectivity in association with various instruments including GC, 
HPLC and others [6-15]. However, each of which had their advantages and disadvantages. 
Therefore, development and validation of the method for MPA analysis in spiked blood 
plasma using internal standard by HPLC method with specific derivatizing agents and 
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clean-up by solid-phase extraction have been carried out. The method sensitivity obtained is 
suitable for pharmacokinetics study of MPA. 
 
Figure 1. Chemical structure of medroxyprogesterone acetate and prednisolone 
Normally, the levels of MPA found in plasma range from 1.75 to 9.0 ng/mL [5]. Formerly, 
the measurement of MPA in a plasma sample was mostly carried out by radioimmunoassay 
(RIA) [6]. Trace analysis of MPA in dog plasma was achieved using cyclohexane extraction, 
followed by heptafluorobutylic anhydride derivatization and gas chromatography with 
electron capture detector (GC-ECD). However, this procedure could not be applied for MPA 
analysis in human plasma due to its high matrix interference. Attempts have been made to 
optimize the methods for MPA analysis using small amounts of plasma samples [7,8]. 
Quantitative analysis of MPA in plasma by HPLC with ultraviolet (UV) detection was also 
carried out, but did not give satisfactory detection limit [9,10]. The high sensitivity of the 
GC-MS has also been used to monitor the MPA level in human serum [11]. This procedure 
used trifluoroacetic anhydride derivatization of the extracted portion after SPE and gave the 
detection limit down to 0.5 ng/mL.  
Although, HPLC-UV analysis of MPA in plasma has been performed, but its sensitivity was 
about 5 ng/mL [12]. In order to enhance both selectivity and sensitivity, recent method 
development and validation of MPA analysis has been focused on HPLC separation with 
various detection systems. HPLC with chemiluminescence detection was used to trace MPA 
in serum via 4-(N,N-dimethylaminosulphonyl) -7-hydrazino-2,1,3-benzoxadiazole as a 
fluorogenic agent [13]. Recently, MPA analysis in plasma sample has been conducted by 
liquid chromatography-electrospray ion trap mass spectrometry (LC-MS/MS) after liquid 
phase extraction and this gave 10 times higher sensitivity than GC-MS [11,14].  
From these reviews, both GC-ECD and HPLC-UV did not give sensitivity high enough for 
MPA analysis in pharmacokinetic studies. In clinical aspects, the RIA method has a rather 
high sensitivity but sometimes gives positive result due to metabolite interference. Both GC-
MS and LC-MS/MS are methods of choice with high selectivity and sensitivity, but may be 
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considerably inconvenient for routine analysis due to the high instrument cost. The HPLC 
with amperometric detector (AD) would be a highly sensitive tool. From the molecular 
structure, MPA is a ketone steroid in which the ketone group can undergo reduction. Since 
the reduction is normally easily interfered by oxygen molecule dissolved in mobile phase, 
this may be a problem [15]. Hydrazines including 2,4-dinitrophenyl hydrazine (DNPH) 
have been introduced as an electroactive labeling reagent for carbonyl compounds [16]. 
Until now there is no report of the derivatization of MPA with DNPH (Fig. 2). From the 
chemical structures condensation reaction can occur between the keto group of MPA and 
DNPH to give the MPA-hydrazone which can be detected by HPLC-AD. The optimum 
conditions of DNPH derivatization with MPA were studied. Therefore, development and 
validation of the method for MPA analysis in spiked blood plasma using prednisolone (P) as 
internal standard (I.S.) by HPLC-AD after derivatization with DNPH and clean-up by solid-
phase extraction have been carried out. The method sensitivity obtained is suitable for 
pharmacokinetic study of MPA. 
 
Figure 2. Derivatizing reaction between 2,4-dinitrophenylhydrazine and ketosteroids giving their 
ketosteroid-2,4-dinitrophenylhydrazones as the derivatized products. 
2. HPLC-AD analysis of MPA in human plasma: A case study 
2.1. Reagents, standard solution and plasma sample 
Medroxyprogesterone acetate (MPA), 99.27%, used as working standard was obtained from 
A.N.B. Laboratory Co. Ltd. (Thailand). Predinisolone was an analytical reagent (A.R.) grade 
from Sigma (Germany). 2,4-Dinitrophenylhydrazine (Fluka, Switzerland) was also of A.R. 
grade. Methanol (MeOH, Merck, Germany), acetonitrile (ACN, Merck, Germany), di-
potassium hydrogen phosphate-3-hydrate (BDH, England) and potassium dihydrogen 
phosphate (BDH, England) were of HPLC grade. Other chemicals used were also A.R. grade 
including hydrochloric acid (Merck, Germany). 
Standard stock solution (500 mg/mL) of MPA was prepared in methanol. Dilute standard 
solutions of MPA were also prepared in methanol. The 2,4-dinitrophenylhydrazine stock 
solution used as a labeling reagent (1,000 mg/mL) was prepared by dissolving the hydrazine 
in 1.2 mL concentrated HCl prior to adjusting the final volume to 25 mL with methanol. 
Stock phosphate solution (2 M) was prepared from sodium dihydrogen phosphate 
monohydrate (NaH2PO4.H2O) in deionized water. A buffer solution of 30 mM potassium 
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dihydrogen phosphate (KH2PO4), pH 3.0 was made by dissolving KH2PO4 in deionized 
water and adjusting to pH 3.0 with 6 M orthophosphoric acid (H3PO4). Mobile phase was 
prepared and used to optimize the separation of the mixture of MPA-DNPH and P-DNPH 
derivatives by amperometric detection (HPLC-AD). The suitable solvent system was 
composed of ACN : MeOH : 30  mM KH2PO4 (pH 3.0) in the ratio of 39 : 39 : 22 by volume 
according to Snyder et al. [17]. The mobile phase was filtered through nylon membrane (0.45 
µm, 47 mm) and degassed for 15 min in ultrasonic bath before use. Sep-pak C18 cartridge, 
100 mg (Waters Associates, U.S.A.) was used. 
Human blood plasma samples were kindly obtained from the Blood Bank, Srinagarin 
Hospital, Khon Kaen University, Khon Kaen, Thailand. 
2.2. Instruments and apparatus 
HPLC system (Perkin Elmer, U.S.A.) used in this study included LC200 HPLC pump with 
electrochemical detector (Coulochem II, ESA, U.S.A.). The standard analytical cell (ESA 5011, 
U.S.A.) consisted of porous graphite working electrode, palladium reference electrode and 
platinum counter electrode. The analytical column used was stainless steel tube packed with 
Hypersil ODS, 5 µm particle size (125 x 4.0 mm i.d., Agilent, U.S.A.). Integrator model1022 
(Perkin Elmer, U.S.A.) was used. UV-Visible spectrophotometer (Cecil 3000, England) was 
also used. Analytical balance (AE 200) and pH meter (Delta 350) were from Mettler (U.S.A.). 
SPE manifold-12 place vacuum manifold (Lida, Germany) was used. Autopipette 
(Eppendorf, Germany) with volume adjustments was used throughout the experiment. 
2.3. Method development and validation 
i. Derivatization of MPA with DNPH  
Study on the hydrazine derivatization of MPA was carried out using 2,4-
dinitrophenylhydrazine (DNPH). The standard solution of MPA (10 mg/mL) was reacted 
with an excess amount of DNPH for an hour. The MPA-DNPH derivative was then injected 
into HPLC with detection at 375 nm [18]. The MPA-DNPH derivatives obtained from 
reacting 0.1 mg MPA with various concentrations (12.5, 25.0, 75.0 and 100.0 mg/mL) of 
DNPH solution in a 2.5 mL capped vial were used to study the effect of DNPH 
concentration and reaction time. 
Prednisolone (P) was also tested for derivatization with DNPH and was used as I.S. There 
should be a single peak and no overlap with any interfering peaks in the sample. The P-
DNPH derivative was obtained from the reaction of 0.10 g DNPH in 10 mL MeOH and 0.48 
mL concentrate HCl with 0.05 g prednisolone [19]. The reaction mixture was placed on a 
heated water bath at 60oC for 30 min, allowed to cool down to room temperature and 
deionized water (60 mL) was added until the derivative product had completely 
precipitated. The derivative product was filtered through a glass filter and washed with 5 
mL 2 M HCl twice, followed by 50 mL deionized water. It was then recrystallized in a 
mixture of chloroform and methanol prior to use. 
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ii. Solid-phase extraction of MPA-DNPH derivative 
The clean up method using solid-phase extraction (SPE) was found to be a critical step for 
plasma sample both before and after derivatization with DNPH. Spiked standard plasma 
(MPA 6 ng/mL) was extracted by Sep-pak C18 cartridge using a mixture of MeOH : H2O as 
extraction solvent. The C18 cartridge was first washed with 2 mL MeOH and followed by 2 
mL water. The spiked plasma (2 mL) was added into the cartridge and then washed with 
2 mL water, followed by 250 mL 50%(v/v) MeOH (3x), and the final elution was made 
with 1 mL MeOH. The MPA extract portion was kept for derivatizing with DNPH. The 
solution of DNPH containing 0.1 mg was added into the MPA extract portion and allowed 
to stand for 30 min, followed by 0.9 mL water and 0.2 mL solution of P-DNPH (10 ng/mL). 
The sample of the derivative mixture was then introduced into the cartridge followed by 3 
times rinsing with 1 mL 50%(v/v) MeOH. The cartridge containing MPA- and P-DNPH 
products was washed by 250 mL 50%(v/v) MeOH (3x) and again allowed to stand for 15 
min before elution by 1 mL MeOH. The elute was then dried over a stream of N2, re-
dissolved in 60 mL MeOH, then 40 mL MeOH added and 60 mL was injected into the 
HPLC system. 
iii. Analysis of MPA-DNPH by RP-HPLC-AD 
The separation of both MPA- and P-DNPH derivatives was carried out on Hypersil ODS 
column by HPLC-AD (0.85 V) using an electrolyte solvent system as mobile phase with a 
flow-rate of 1 mL/min. The mobile phase of ACN : MeOH : 30 mM KH2PO4 (pH 3.0) (30 : 39 : 
22, v/v/v) was used in this experiment after optimization of buffer concentration, pH and 
organic modifier. Both MPA standard solution and MPA spiked plasma sample were 
prepared at the concentrations of 0.5, 1, 2, 4, 6 and 8 ng/mL. 
iv. Method sensitivity of MPA analysis in spiked plasma sample 
Various concentrations of MPA spiked in a plasma sample with 10 ng/mL P-DNPH as I.S. 
were extracted by Sep-pak C18 cartridge, and run by HPLC-AD (0.85 V) [20,21]. Limit of 
detection (LOD) is the concentration of MPA giving a peak height 3 times the baseline noise 
(3SD) and the limit of quantitation (LOQ) is defined as 10SD. The standard curve was 
obtained from the concentrations of 0.5, 1, 2, 4, 6, 8 and 10 ng/mL. The accuracy and 
precision including recovery were determined at three concentration levels (1, 4 and 8 
ng/mL) of the spiked plasma standard. 
3. Results and discussion 
For method development, studies on derivatization of some hydrazines with MPA had been 
carried out in acidic solution [15]. It was found that DNPH is a suitable reagent. Many 
internal standards having similar core structure which is derivatized with DNPH were also 
investigated by the same manner [19]. Prednisolone was found to be the most suitable 
ketosteroid and its derivatized solid product was prepared. It was eluted along with the 
MPA-DNPH and was used as I.S. throughout the experiment. 
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Effects of derivatization time and concentration of DNPH for MPA analysis were studied. 
The DNPH concentrations used were 12.5, 25, 75 and 100 mg/mL. MPA (100 ng/mL) was 
used to react with various concentrations of DNPH in the ratio of 1 : 1 at room temperature 
and their reaction times were also done up to 180 min (Fig. 3). It was found that 75 mg/mL 
of DNPH gave the highest peak area within 120 min derivatization time. In this study, the 
derivatization time of 30 min wasenough, since the signal output was not significantly 
different from that of 120 min derivatization.  
 
Figure 3. Effects of reaction times and concentrations on the derivatization of DNPH with 100 ng/mL 
MPA at room temperature. 
The effect of temperature for 30 min derivatization was also investigated using 100 ng/mL 
MPA and 75 mg/mL DNPH in acidic solution. There seemed to be no effect of temperature, 
except a linear increase of peak area when the reaction was performed at room temperature 
(Fig. 4). Thus, the reaction was rapidly completed at room temperature. 
Concerning on RP-HPLC-AD analysis, the optimization conditions of the HPLC-AD for 
MPA-DNPH analysis were then investigated. Effects of pH (3-6) and buffer concentration 
(10-40 mM) on mobile phase (ACN : phosphate buffer) were carried out. It was found that 
the optimum buffering system was at pH 3.0 and 30 mM phosphate buffer (data not shown). 
In addition, the ratios of organic solvents were investigated and a good separation was 
obtained with the mobile phase of ACN : MeOH : 30 mM phosphate buffer (pH 3.0) at the 
ratio of 39 : 39 : 22 by volume. 
Figure 5 shows the hydrodynamic voltammogram (HDV) of MPA- and P-DNPH 
derivatives. The optimum potential that gave the highest peak area was around 0.8-0.9 V for 
both derivatized products, and 0.85 V was used in this study. 
For method validation, the method limits for detection and quantitation were found to be 
0.2 and 1.0 ng/mL with lower 15% precision and 80 - 120% accuracy, respectively. In Table 1, 
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the results for intra-day and inter-day precision were 5.05 and 11.5 %RSD, respectively. The 
intra-day accuracy ranged from 102.2 - 109.5%. The average recovery was found to be 102.9 
+ 4.4%. It was found that this electrochemical detection was considerably selective and gave 
a working range of 1.0 - 10.0 ng/mL with linear regression: y = (3.17 + 0.12) x – (0.67 + 0.03), r2 
= 0.9985 for n = 5 with %RSD = 2.34 – 7.96. 
 
Figure 4. Effect of temperatures on the derivatization reaction of DNPH (75 mg/mL) and MPA (100 
ng/mL) between 5 min and 30 min. 
 
Figure 5. Effect of applied voltammetric potentials on the peak areas of MPA- and P-DNPH derivatives. 
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Concentrationa 
(ng/mL) 
Intra-day 
RSD (%) 
Inter-dayb 
RSD (%) 
Recoveryc 
(%) 
1.0 7.76 15.4 107.3 
4.0 5.06 9.62 98.55 
8.0 2.35 9.55 102.9 
Mean + SD 5.05 + 2.7 11.5 + 3.4 102.9 + 4.4 
Table 1. Intra-day and inter-day precision and method recovery of MPA-DNPH derivative. 
an = 5 
bwithin three consecutive days 
cMean of three determinations 
RSD, relative standard deviation 
Since the method sensitivity of MPA analysis was the main objective of this study, it has 
been shown that the clean-up step, using the SPE method for MPA spiked in human plasma 
sample, was necessary probably due to both the reagent used and the sample interference 
matrices (Fig. 6, a-d). The solution of MPA-DNPH derivative products with excess DNPH 
was not clean enough, so it must be added through the Sep-pak cartridge before being 
separated on the HPLC-AD system. Without the clean-up step, there might be trouble for 
the HPLC column used, which may affect the analytical sensitivity as well. This is the first 
report of the use of DNPH as an electroactive labeling reagent for MPA analysis. 
Development and validation of the HPLC-AD of the derivatized product were then carried 
out. The MPA-DNPH was completely separated from the I.S. within a suitable analysis time 
(Fig. 6, a-d). 
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Figure 6. Chromatogram obtained from (a) blank reagent. (b) standard solution of (1) MPA-DNPH (10 
ng/mL) and (2) P-DNPH as I.S. (c) blank of blood plasma sample, (d) blood plasma spiked with (1) 
MPA-DNPH (10 ng/mL) and (2) P-DNPH as I.S. (inset, (1) MPA-DNPH, 1 ng/mL). 
Instrument Extraction method Sample size (mL) LOD (ng/mL) Reference 
GC-ECDa liquid phase 4 1-5 [7,8] 
GC-MSb solid phase 1 0.5 [11] 
LC-MS/MSc liquid phase 1 0.05 [14] 
HPLC-UVd solid phase 2 4 [9] 
HPLC-PO-Cle liquid phase 0.1 9 [13] 
HPLC-ADf solid phase 2 0.2 This work 
Table 2. Some analytical methods and limits of detection of MPA analysis in plasma samples. 
aelectron capture detection of MPA derivative 
bmass spectrometric detection of MPA derivative 
ctandem mass spectrometry 
dultraviolet (254 nm) detection of MPA 
eperoxyoxalate chemiluminescence (λex/λem : 480/570 nm) detection of MPA derivative 
fvoltammetric (0.85 V) detection of MPA-DNPH derivative 
LOD, limit of detection 
The plasma sample size used in this study was still rather high (2 mL) for clinical aspects 
when compared with other reports [11,13,14], giving LOD and LOQ of 0.2 and 1.0 ng/mL, 
respectively. Thus, the developed method with electrochemical detection has sufficiently 
high sensitivity when compared with other methods, except for the tandem MS, as shown in 
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Table 2. It is, however, satisfactory for pharmacokinetic study of trace MPA in plasma 
sample, especially in the case of contraceptive administration with very low dose. Since it is 
rapid procedure and inexpensive, this technique is suitable for routine analysis of the MPA 
content in most pharmaceutical products and blood samples. 
4. Conclusion 
A specific and sensitive method is presented for the analysis of medroxyprogesterone 
acetate (MPA) in human plasma using reversed phase high-performance liquid 
chromatography (HPLC) with amperometric detection. The blood sample spiked with trace 
amount of MPA was cleaned up to remove natural interfering matrices by solid-phase 
extraction (SPE). The MPA extract was then derivatized with 2,4-dinitrophenylhydrazine 
(DNPH) as an electroactive agent. The MPA-DNPH derivative was re-extracted using SPE 
prior to analysis by reversed phase HPLC. Quantitative analysis of the MPA-DNPH using 
prednisolone-DNPH as an internal standard were optimized on a Hypersil ODS column 
using acetonitrile : methanol : 30 mM phosphate buffer, pH 3.0 (39 : 39 : 22, v/v/v) as mobile 
phase at a flow-rate of 1.0 mL/min. It was found that the method was selective and gave 
linear calibration curve for a concentration range of 1.0 - 10.0 ng/mL for 2 mL spiked plasma 
samples. The relative standard deviation (RSD) of inter-day precision for a period of three 
validation days was 11.5 + 3.4% for all concentration used. The RSD of intra-day precision (n 
= 5) was 5.05 + 2.7% with accuracy (n = 5) of 102.3 + 7.4%. The average recovery was found to 
be 102.9 + 4.4%. The correlation coefficient of the calibration curve was 0.9985. The limits of 
detection and quantitation were found to be 0.2 and 1.0 ng/mL, respectively. Using DNPH 
as a derivatizing agent can enhance both selectivity and sensitivity of MPA in plasma and is 
suitable for routine analysis. 
5. Abbreviations 
ACN:  Acetonitrile 
Depot-MPA: Depot-medroxyprogesterone acetate 
DNPH:  2,4-Dinitrophenylhydrazine 
GC-ECD: Gas chromatography-electron capture detection 
GC-MS:  Gas chromatography-mass spectrometry 
HCl:  Hydrochloric acid 
HDV:  Hydrodynamic voltammogram 
HPLC-UV: High-performance liquid chromatography with ultraviolet detection 
HPLC-PO-Cl: High-performance liquid chromatography with peroxyoxalate 
  chemiluminescence 
I.S.:  Internal standard 
LC-MS/MS: Liquid chromatography-mass spectrometry/mass spectrometry 
LOD:  Limit of detection 
LOQ:  Limit of quantitation 
MeOH:  methanol 
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MPA:   Medroxyprogesterone acetate 
MPA-DNPH:  Medroxyprogesterone acetate-2,4-Dinitrophenylhydrazone 
mM:  Millimolar 
mg/mL:  Milligram per milliliter 
M:  Molar 
ng/mL:  Nanogram per milliliter 
ODS:  Octadecylsilane 
P-DNPH: Prednisolone-2,4-Dinitrophenylhydrazone 
RP-HPLC-AD:  Reversed phase high-performance liquid chromatography 
  with amperometric detection 
RSD:   Relative standard deviation 
SD:   Standard deviation 
SPE:   Solid-phase extraction 
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